Maravai LifeSciences Holdings, Inc. (MRVI) vs First Tracks Biotherapeutics, Inc. (TRAX)
- Maravai LifeSciences Holdings, Inc. MRVI 7.52 +7.74%
- First Tracks Biotherapeutics, Inc. TRAX 47.78 +5.17%
Maravai LifeSciences Holdings, Inc. and First Tracks Biotherapeutics, Inc. are both Biotechnology companies. Maravai LifeSciences Holdings, Inc. and First Tracks Biotherapeutics, Inc. are of similar size ($1.9B and $1.8B). First Tracks Biotherapeutics, Inc. has the higher net margin (0.00% vs −30.8%) and the higher return on invested capital (0.00% vs −13.6%). Across the 11 metrics below, First Tracks Biotherapeutics, Inc. leads on 8 and Maravai LifeSciences Holdings, Inc. on 3.
Valuation
Profitability
| Metric | MRVI | TRAX | Biotechnology median |
|---|---|---|---|
| Gross margin | 39.15% | — | 68.51% |
| Operating margin | (45.38%) | 0.00% | 0.00% |
| Net margin | (30.83%) | 0.00% | 0.00% |
| Free cash flow margin | (5.89%) | 0.00% | 0.00% |
| Return on equity | (17.01%) | 0.00% | (51.96%) |
| Return on assets | (9.06%) | 0.00% | (46.06%) |
| Return on invested capital | (13.62%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack